Guardion Health Sciences, Inc. Made Headway
Guardion Health Sciences, Inc. (GHSI:NASDAQ) rocketted at $0.47, representing a gain of 54%. On Wed 26 Feb 20, GHSI:NASDAQ touched a New 2-Week High of $0.31. The stock got featured on our News Catalysts scanner on Thu 06 Feb 20 at 08:19 AM in the 'BIOTECH' category. From Wed 05 Feb 20, the stock recorded 35.71% Up Days and 20.00% Green Days
The stock spiked on Mon 06 Jan 20 at $0.5 with a volume of 46M+, and its share price has been moving sideways in recent weeks.
About Guardion Health Sciences, Inc. (GHSI:NASDAQ)
Guardion Health Sciences Inc is a specialty health sciences company formed to develop, formulate and distribute condition-specific medical foods with an initial medical food product. The company's Lumega-Z, is a micronized lipid-base nutritional formulation designed to restore and maintain the condition of a depleted macular pigment. It has also developed GlaucoCetin, the first regulated vision-specific Medical Food designed to support and protect the mitochondrial function of optic nerve cells in patients with glaucoma.
Top 10 Gainers:
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 321.74%
- iBio, Inc. (IBIO:NYSEMKT), 158.98%
- Alpha Pro Tech, Ltd. (APT:NYSEMKT), 103.79%
- Tonix Pharmaceuticals Holding Corp. (TNXP:NASDAQ), 92.22%
- Co-Diagnostics, Inc. (CODX:NASDAQ), 79.33%
- Vir Biotechnology, Inc. (VIR:NASDAQ), 72.12%
- GAIN Capital Holdings, Inc. (GCAP:NYSE), 66.01%
- Aethlon Medical, Inc. (AEMD:NASDAQ), 58.73%
- Guardion Health Sciences, Inc. (GHSI:NASDAQ), 54.05%
- Vaxart, Inc. (VXRT:NASDAQ), 49.7%